Results 21 to 30 of about 4,210,891 (389)
Archives of Public Health, 2022 We would like to thank authors Reece and Hulse (2022) for their three-part article titled “Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer ...
Frank Yizhao Chen +2 more
doaj +1 more source
The Immunopathology of COVID-19 and the Cannabis Paradigm
Frontiers in Immunology, 2021 Coronavirus disease-19 caused by the novel RNA betacoronavirus SARS-CoV2 has first emerged in Wuhan, China in December 2019, and since then developed into a worldwide pandemic with >99 million people afflicted and >2.1 million fatal outcomes as of ...
Nicole Paland +8 more
doaj +1 more source
Expert Review of Clinical Pharmacology, 2023 Background There is a paucity of high-quality data on patient outcomes and safety after initiating treatment with cannabis-based medicinal products (CBMPs).
Fabian Olsson +11 more
semanticscholar +1 more source
High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs
Frontiers in Immunology, 2022 Cytokine storm refers to the dysregulated production of inflammatory mediators leading to hyperinflammation. They are often detrimental, and worsen the severity of COVID-19 and other infectious or inflammatory diseases.
Miran Aswad +8 more
doaj +1 more source
Three Decades of Cannabis Research: What are the Obstacles?
Rambam Maimonides Medical Journal, 2022 During the past few years, thousands of articles have been published concerning medical cannabis useage. Unfortunately, most publications are case studies or small and poorly designed research projects. In attempting to understand the reasons behind this
Michael Dor
doaj +1 more source
Medical Cannabis in Children [PDF]
Rambam Maimonides Medical Journal, 2020 The use of medical cannabis in children is rapidly growing. While robust evidence currently exists only for pure cannabidiol (CBD) to treat specific types of refractory epilepsy, in most cases, artisanal strains of CBD-rich medical cannabis are being used to treat children with various types of refractory epilepsy or irritability associated with autism
Adi Aran, Dalit Cayam-Rand
openaire +3 more sources
JAMA Network Open, 2023 Key Points Question Is receiving medical cannabis for a longer duration associated with reducing prescription opioid dosages among patients receiving long-term opioid therapy?
Trang Nguyen +4 more
semanticscholar +1 more source
Cannabis sativa: Difference between Medical Cannabis (Maijuana or drug type) and Industrial hemp
GSC Biological and Pharmaceutical Sciences, 2023 This paper reviewed the importance of Cannabis sativa and highlights difference between Medical Cannabis (Maijuana or drug type) and Industrial hemp.
Ravindra B. Malabadi +3 more
semanticscholar +1 more source
Australian Journal of General Practice, 2021 Medical cannabis use is increasingly common in Australia. Patients and physicians need to be aware of the important implications that such use may have for driving.The aim of this article is to briefly review the scientific evidence regarding cannabis and driving impairment and discuss current legal issues affecting patients, as well as to update ...
Arkell, Thomas R. +2 more
openaire +3 more sources
State Variation in U.S. Medical Cannabis Limits, Restrictions, and Therapeutic Cannabis Dosing
Cannabis, 2023 Wide variation exists in the possession limits of cannabis products sold for medical use in the U.S. as well as the tetrahydrocannabinol (THC) content of cannabis products.
Shelby R. Steuart
semanticscholar +1 more source